The extracellular signal-regulated kinase-mitogen-activated protein kinase pathway phosphorylates and targets Cdc25A for SCFβ-TrCP- dependent degradation for cell cycle arrest

Molecular Biology of the Cell

Volumn 20, Issue 8, 2009, Pages 2186-2195

  Isoda, Michitaka ^a   Kanemori, Yoshinori ^a   Nakajo, Nobushige ^a   Uchida, Sanae ^b   Yamashita, Katsumi ^b   Ueno, Hiroyuki ^a   Sagata, Noriyuki ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; CULLIN; F BOX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE; S PHASE KINASE ASSOCIATED PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENOTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; XENOPUS;

AMINO ACID SEQUENCE; ANIMALS; BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; BIOCATALYSIS; CDC25 PHOSPHATASES; CELL CYCLE; CELL DIFFERENTIATION; EMBRYO, NONMAMMALIAN; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OVUM; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SKP CULLIN F-BOX PROTEIN LIGASES; XENOPUS; XENOPUS PROTEINS;

EID: 65249093722     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-01-0008     Document Type: Article

References (40)

1. Alonso, G., Ambrosino, C., Jones, M., and Nebreda, A. R. (2000). Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275, 40641-40648.
2. Bartek, J., and Lukas, J. (2003). Chkl and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429.
3. Bitangcol, J. C., Chau, A.S.S., Stadnick, E., Lohka, M. J., Dicken, B., and Shibuya, E. K. (1998). Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts. Mol. Biol. Cell 9, 451-467.
4. Busino, L., Donzelli, M., Chiesa, M., Guadavaccaro, D., Ganoth, D., Dorrello, N. V., Hershko, A., Pagano, M., and Draetta, G. F. (2003). Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage. Nature 426, 87-91.
5. Donzelli, M., and Draetta, G. F. (2003). Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 4, 671-677.
6. Ducruet, A. P., and Lazo, J. S. (2003). Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity. J. Biol. Chem. 278, 31838-31842.
7. Ebisuya,M.,Kondoh,K.,and Nishida,E. (2005). Theduration,magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J. Cell Sci. 118, 2997-3002.
8. Frescas, D., and Pagano, M. (2008). Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438-449.
9. Frodin, M., and Gammeltoft, S. (1999). Role and regulation of 90 kDa ribo-somal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151, 65-77.
10. Hoffmann, I., Draetta, G., and Karsenti, E. (1994). Activation of the phospha-tase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13, 4302-4310.
11. Inoue, D., Ohe, M., Kanemori, Y., Nobui, T., and Sagata, N. (2007). A direct link of the Mos-MAPK pathway to Erp1/Emi2 in meiotic arrest of Xenopus laevis eggs. Nature 446, 1100-1104.
12. β-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17, 3062-3074.
13. Kanemori, Y., Uto, K., and Sagata, N. (2005). β-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc. Natl. Acad. Sci. USA 102, 6279-6284.
14. Khaled, A. R., Bulavin, D. V., Kittipatarin, C., Li, W. Q., Alvarez, M., Kim, K., Young, H. A., Fornace, A. J., and Durum, S. K. (2005). Cytokine-driven cell cycling is mediated through Cdc25A. J. Cell Biol. 169, 755-763.
15. Kim, S.H.Li.C., and Maller, J. L. (1999). A maternal form of the phosphatase Cdc25A regulates early embryonic cell cycles in Xenopus laevis. Dev. Biol. 212, 381-391.
16. Kishimoto, T. (2003). Cell cycle control during meiotic maturation. Curr. Opin. Cell Biol. 15, 654-663.
17. Lei, K., Nimnual, A., Zong, W. X., Kennedy, N. J., Flavell, R. A., Thompson, C. B., Bar-Sagi, D., and Davis, R. J. (2002). The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol. Cell. Biol. 22, 4929-4942.
18. Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., and Lowe, S. W. (1998). Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008-3019.
19. Mailand, N., Falck, J., Lukas, C., Syljuasen, R. G., Welcker, M., Bartek, J., and Lukas, J. (2000). Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429.
20. Manke, I. A., Nguyen, A., Lim, D., Stewart, M. Q., Elia, A. E., and Yaffe, M. B. (2005). MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17, 37-48.
21. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., and Arm, N. G. (1994). Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970.
22. Meloche, S., and Pouyssegur, J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 26, 3227-3239.
23. Molinari, M., Mercurio, C., Dominguez, J., Goubin, F., and Draetta, G. F. (2000). Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep., 1, 71-79.
24. Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., and Arkinstall, S. (1996). The dual specificity phosphatases M3/6 and MKP-3 are highlyselective for inactivation ofdistinct mitogen-activated protein kinases. J. Biol. Chem. 271, 27205-27208.
25. Murakami, M. S., and Vande Woude, G. F. (1998). Analysis of the early embryonic cell cycles of Xenopus; regulation of cell cycle length by Xe-wee1 and Mos. Development 125, 237-248.
26. Nishiyama, T., Ohsumi, K., and Kishimoto, T. (2007). Phosphorylation of Erp1 by p90rsk is required for cytostatic factor arrest in Xenopus laevis eggs. Nature, 446, 1096-1099.
27. Okamoto, K., and Sagata, N. (2007). Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase. Proc. Natl. Acad. Sci. USA 104, 3753-3758.
28. Pumiglia, K. M., and Decker, S. J. (1997). Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 94, 448-452.
29. Raman, M., Chen, W., and Cobb, M. H. (2007). Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112.
30. Reinhardt, H. C., Aslanian, A. S., Lees, J. A., and Yaffe, M. B. (2007). p53-deficient cells rely on ATM-and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathwayfor survival after DNA damage. Cancer Cell 11, 175-189.
31. Sagata, N. (1997). What does Mos do in oocytes and somatic cells? Bioessays 19, 13-21.
32. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
33. Shimuta, K., Nakajo, N., Uto, K., Hayano, Y., Okazaki, K., and Sagata, N. (2002). Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition. EMBO J. 21, 3694-3703.
34. Solc, P., Saskova, A., Baran, V., Kubelka, M., Schultz, R. M., and Motlik, J. (2008). CDC25A phosphatase controls meiosis I progression in mouse oocytes. Dev. Biol. 317, 260-269.
35. Sturgill, T. M., Ray, L. B., Erikson, E., and Maller, J. L. (1988). Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334, 715-718.
36. Uto, K., Inoue, D., Shimuta, K., Nakajo, N., and Sagata, N. (2004). Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J. 23, 3386-3396.
37. Walter, S. A., Guadagno, T. M., and Ferrell., J. E., Jr. (1997). Induction of a G2-phase arrest in Xenopus egg extracts by activation of p42 mitogen-activated protein kinase. Mol. Biol. Cell. 8, 2157-2169.
38. Yamanaka, H., Moriguchi, T., Masuyama, N., Kusakabe, M., Hanafusa, H., Takeda, R., Takeda, S., and Nishida, E. (2002). JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates. EMBO Rep. 3, 69-75.
39. Watanabe, N., Arai, H., Iwasaki, J.-I., Shiina, M., Ogata, K., Hunter, T., and Osada, H. (2005). Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc. Natl. Acad. Sci. USA 102, 11663-11668.
40. Zhu, J., Woods, D., McMahon, M., and Bishop, J. M. (1998). Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007.